Home > Insider Trading > Filing (0001144204-14-016512)

Filing Details

Accession Number:: 0001144204-14-016512
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2014-03-18 20:44:13
Reporting Period:: 2014-03-12

Filing Date:: 2014-03-18
Accepted Time:: 2014-03-18 20:44:13
Original Submission Date:: 2014-03-14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1023024	Ani Pharmaceuticals Inc	ANIP	Pharmaceutical Preparations (2834)	582301143

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1068854	Daniel Raynor	C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-03-12	19,213	$33.85	538,427	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2014-03-12	1,898	$34.35	536,529	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

On March 14, 2014, the reporting person filed a Form 4 that reported sales of the Issuer's securities, which Form 4 contained an inadvertent error in the amount of securities beneficially owned following the reported sales transaction. This Form 4 also corrects the method of reporting the prices of the securities sold.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.21 to $34.20 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by him at each separate price on each date of sale.
These shares are held by Argentum Capital Partners II, L.P. (ACP II). Argentum Investments, LLC is the managing member of Argentum Partners II, LLC, which is the general partner of ACP II. Daniel Raynor is a co-managing member of Argentum Investments, LLC. Mr. Raynor disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. The business address of ACP II is 60 Madison Avenue, Suite 701, New York, NY 10010.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.21 to $34.55 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by him at each separate price on each date of sale.